Fenofibrate improves heart failure outcomes in patients with type 2 diabetes: ACCORD Lipid trial
Porto, Portugal: Recent data from the ACCORD Lipid trial showed that fenofibrate reduces the composite of HF hospitalizations or cardiovascular mortality in type 2 diabetes (T2D) patients treated with...
Source: medicaldialogues.in